We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
201
Osaic Holdings
Arizona
$3.29M -$593K -5,752 -16%
LCG
202
Lisanti Capital Growth
New York
$3.26M -$272K -2,640 -8%
TRSOTSOK
203
Teachers Retirement System of the State of Kentucky
Kentucky
$3.19M +$1.38M +13,356 +83%
RGC
204
Roberts, Glore & Co
Illinois
$3.1M -$22.3K -216 -0.7%
RHJA
205
Rice Hall James & Associates
California
$3.02M -$37.6K -364 -1%
URS
206
Utah Retirement Systems
Utah
$3.02M -$41.3K -400 -1%
RG
207
Rathbones Group
United Kingdom
$2.96M +$2.82M +27,360 New
TRCT
208
Tower Research Capital (TRC)
New York
$2.94M +$2.04M +19,796 +268%
SLAM
209
Swiss Life Asset Management
$2.93M -$153K -1,480 -5%
BM
210
Bridger Management
New York
$2.9M -$208K -2,016 -7%
X
211
Xponance
Pennsylvania
$2.88M +$33.8K +328 +1%
YCM
212
Yousif Capital Management
Michigan
$2.85M -$666K -6,452 -20%
GIBU
213
Gulf International Bank (UK)
United Kingdom
$2.83M
SCI
214
S&CO Inc
Massachusetts
$2.82M
State of Tennessee, Department of Treasury
215
State of Tennessee, Department of Treasury
Tennessee
$2.72M -$2.67M -25,840 -51%
AF
216
Affiance Financial
Minnesota
$2.71M -$195K -1,892 -7%
AAM
217
Azzad Asset Management
Virginia
$2.65M +$58.6K +568 +2%
BCIM
218
British Columbia Investment Management
British Columbia, Canada
$2.63M -$325K -3,148 -11%
CAM
219
Crown Advisors Management
California
$2.6M
FAM
220
Formidable Asset Management
Ohio
$2.58M -$815K -7,896 -25%
II
221
IFM Investors
Australia
$2.53M +$380K +3,680 +19%
Handelsbanken Fonder
222
Handelsbanken Fonder
Sweden
$2.53M -$289K -2,800 -11%
MSL
223
Mackay Shields LLC
New York
$2.5M -$75.1K -728 -3%
SWMG
224
Sanchez Wealth Management Group
Florida
$2.45M +$1.24K +12 +0.1%
Public Sector Pension Investment Board (PSP Investments)
225
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.38M -$442K -4,280 -16%

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.